News › Clinical Practice, Industry News

Demand for Noninvasive Fat Reduction Dropped by 40 Percent in 2024

July 18, 2025

The American Society of Plastic Surgeons recently released its annual report on the number of surgical and minimally invasive cosmetic procedures performed. Noninvasive fat reduction (e.g., CoolSculpting, Liposonix, Emsculpt, Vanquish, Zerona, Kybella) was down 40% year over year, from 745,957 procedures in 2023 to 439,032 in 2024.

Industry experts who spoke to Allure suggest that this decline in popularity for noninvasive procedures is based on many factors, including the rise in GLP-1 medical weight loss programs, the relative cost-effectiveness of other procedures to target large areas, and public apprehension over highly publicized cases of paradoxical adipose hyperplasia (PAH) after CoolSculpting.

Read the 2024 ASPS Procedural Statistics at ASPS >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
Advertisement